# US 2015/0106960 A1 · Method for diagnosing a skeletal ciliopathy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0106960 A1
- Document ID: US20150106960A1
- Status: Published application
- Kind: A1
- Application number: 14/391,172
- Filed: 2013-04-10
- Published: 2015-04-16
- Earliest claimed: 2012-04-11
- Assignees: Inserm (Institut National De La Sante Et De La Recherche Medicale); Assistance Publique-Hopitaux de Paris; Universite Paris Descartes; Fondation Imagine
- Applicants: Inserm (Institut National De La Sante Et De La Recherche Medicale); Assistance Publique Hopitaux De Paris; Universite Paris Descartes; Fondation Imagine
- Inventors: Valerie Cormier-Daire; Josseline Kaplan; Isabelle Perrault; Jean-Michel Rozet; Arnold Munnich; Sophie Saunier
- Web page: https://patentgrep.com/patent/US20150106960A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- A01K 67/0275: Genetically modified vertebrates, e.g. transgenic
- A01K 2267/0306: Animal model for genetic diseases
- C12Q 2600/118: Prognosis of disease development
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- A01K: ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS

## Abstract

The present invention relates to a method for diagnosing a skeletal ciliopathy.

## Claims

### Claim 1

A method for diagnosing a skeletal ciliopathy in a subject, said method comprising detecting a mutation in the IFT140 gene in a biological sample obtained from said subject, wherein the presence of an IFT140 mutation is indicative of a skeletal ciliopathy or a risk of having a skeletal ciliopathy.

### Claim 2 (depends on 1)

The method according to claim 1 wherein the IFT140 mutation is homozygous.

### Claim 3 (depends on 1)

The method according to claim 1 wherein the subject has a retinal dystrophy.

### Claim 4

A method for predicting a risk of a subject to transmit a skeletal ciliopathy to his infants, said method comprising detecting a mutation in the IFT140 gene in a biological sample obtained from said subject, wherein the presence of an IFT140 mutation is indicative of a risk of transmitting a skeletal ciliopathy.

### Claim 5 (depends on 1)

The method according to claim 1 wherein the skeletal ciliopathy is a Mainzer Saldino Syndrome or a Jeune Syndrome.

### Claim 6 (depends on 1)

The method according to claim 1 wherein the skeletal ciliopathy is a Mainzer Saldino Syndrome.

### Claim 7

A method for detecting a subject carrying a defective IFT140 gene, which method comprises detecting a mutation in the IFT140 gene in a biological sample obtained from said subject.

### Claim 8 (depends on 1)

The method according to claim 1 wherein the IFT140 mutation results in a defect in ciliogenesis and/or cilia maintenance.

### Claim 9 (depends on 1)

The method according to claim 1 wherein the IFT140 mutation is a missense mutation, a donor splice mutation or a truncating mutation.

### Claim 10 (depends on 1)

The method according to claim 1 wherein the IFT140 mutation is selected from the group consisting of c.2399+1G>T, c.932A>G, c.1990G>A, c.634G>A, c.699T>G, c.1565G>A, c.874G>A, c.1727G>A, c.489C>T, c.857—860delTTGA and c.3916dup.

### Claim 11

(canceled)

### Claim 12

A method for treating a skeletal ciliopathy with comprises the step of administering a IFT140-encoding polynucleotide to a patient in need thereof.

### Claim 13 (depends on 12)

The method according to claim 12 wherein the skeletal ciliopathy is a Mainzer Saldino Syndrome.

### Claim 14

A transgenic non-human animal which is IFT140-deficient.
